Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Medecine Sciences : M/S
|
December 21, 2013
[Programmed cell death comes in many flavors]
Lauriane Cabon, Ana-Carolina Martinez-Torres, Santos A Susin
Methods in Cell Biology
|
January 17, 2025
Splenocytes antitumor cytotoxicity assessment after prophylactic vaccination or drug treatment of tumor-bearing mice
Kenny Misael Calvillo-Rodriguez, Ana Luisa Rivera-Lazarin, Reyes Tamez-Guerra, et al.
Methods in Cell Biology
|
October 17, 2025
Saphenous vein blood collection for different immune analyses of living mice
Kenny Misael Calvillo-Rodriguez, Kassandra Ofelia Rodriguez-Aguillon, Reyes Tamez-Guerra, et al.
Methods in Cell Biology
|
January 17, 2025
Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death
Kenny Misael Calvillo-Rodriguez, Maria Norma Gonzalez-Flores, Reyes Tamez-Guerra, et al.
Peerj
|
October 4, 2019
Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
Ana Carolina Martinez-Torres, Luis Gomez-Morales, Alan B Martinez-Loria, et al.
Plos One
|
August 8, 2012
CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice
Vu Quang Van, Nobuyasu Baba, Manuel Rubio, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies
Thomas Denèfle, Héloise Boullet, Linda Herbi, et al.
Journal of Medicinal Chemistry
|
August 13, 2019
Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells
Thomas Denèfle, Elodie Pramil, Luis Gómez-Morales, et al.
Plos Medicine
|
March 4, 2015
CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans
Ana-Carolina Martinez-Torres, Claire Quiney, Tarik Attout, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 6, 2025
High- and low-risk human papillomavirus prevalence in sinonasal inverted papilloma, a retrospective study
Gerardo C Palacios-Saucedo, Jose Manuel Vazquez-Guillen, Aldo Sebastian Flores-Flores, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Medecine Sciences : M/S
|
December 21, 2013
[Programmed cell death comes in many flavors]
Lauriane Cabon, Ana-Carolina Martinez-Torres, Santos A Susin
Methods in Cell Biology
|
January 17, 2025
Splenocytes antitumor cytotoxicity assessment after prophylactic vaccination or drug treatment of tumor-bearing mice
Kenny Misael Calvillo-Rodriguez, Ana Luisa Rivera-Lazarin, Reyes Tamez-Guerra, et al.
Methods in Cell Biology
|
October 17, 2025
Saphenous vein blood collection for different immune analyses of living mice
Kenny Misael Calvillo-Rodriguez, Kassandra Ofelia Rodriguez-Aguillon, Reyes Tamez-Guerra, et al.
Methods in Cell Biology
|
January 17, 2025
Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death
Kenny Misael Calvillo-Rodriguez, Maria Norma Gonzalez-Flores, Reyes Tamez-Guerra, et al.
Peerj
|
October 4, 2019
Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
Ana Carolina Martinez-Torres, Luis Gomez-Morales, Alan B Martinez-Loria, et al.
Plos One
|
August 8, 2012
CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice
Vu Quang Van, Nobuyasu Baba, Manuel Rubio, et al.
Journal of Medicinal Chemistry
|
August 17, 2016
Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies
Thomas Denèfle, Héloise Boullet, Linda Herbi, et al.
Journal of Medicinal Chemistry
|
August 13, 2019
Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells
Thomas Denèfle, Elodie Pramil, Luis Gómez-Morales, et al.
Plos Medicine
|
March 4, 2015
CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans
Ana-Carolina Martinez-Torres, Claire Quiney, Tarik Attout, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 6, 2025
High- and low-risk human papillomavirus prevalence in sinonasal inverted papilloma, a retrospective study
Gerardo C Palacios-Saucedo, Jose Manuel Vazquez-Guillen, Aldo Sebastian Flores-Flores, et al.
Page
of 2